Drug Type Small molecule drug |
Synonyms prucalopride, Prucalopride succinate (USAN), Resotran + [14] |
Target |
Mechanism 5-HT4 receptor agonists(Serotonin 4 (5-HT4) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (14 Oct 2009), |
Regulation- |
Molecular FormulaC22H32ClN3O7 |
InChIKeyQZRSNVSQLGRAID-UHFFFAOYSA-N |
CAS Registry179474-85-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10152 | Prucalopride Succinate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Chronic idiopathic constipation | US | 14 Dec 2018 | |
Constipation | AU | 07 Oct 2011 | |
Chronic constipation | EU | 14 Oct 2009 | |
Chronic constipation | IS | 14 Oct 2009 | |
Chronic constipation | LI | 14 Oct 2009 | |
Chronic constipation | NO | 14 Oct 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 3 | CA | 01 Mar 2014 | |
Gastroparesis | Phase 3 | CA | 01 Mar 2014 | |
Intestinal preparation | Phase 3 | CA | 01 Jun 2013 | |
Constipation - functional | Phase 3 | NL | 28 Apr 2011 | |
Chronic Pain | Phase 3 | BE | 19 May 2010 | |
Opioid-Induced Constipation | Phase 3 | BE | 19 May 2010 | |
Intestinal Pseudo-Obstruction | Phase 2 | GB | 19 Nov 2008 | |
Liver Diseases | Phase 1 | RU | 01 May 2010 |
Not Applicable | - | - | krzlchzupv(furithvuzg) = eugcnobnij omhuggwoah (jchqjbvvhf ) | - | 13 Oct 2024 | ||
(Fasting) | krzlchzupv(furithvuzg) = ozqcynhjtu omhuggwoah (jchqjbvvhf ) | ||||||
Phase 3 | 175 | Placebo (Part A: Placebo) | ordmrzltnx(pqmtcurogk) = syfqdqvtzr rxbnpxavlr (ihuyiytxbm, sddkubmzuq - igmdtfaoma) View more | - | 06 Jun 2024 | ||
(Part A: Low Dose Prucalopride) | ordmrzltnx(pqmtcurogk) = ufoxfuuzny rxbnpxavlr (ihuyiytxbm, hthougjcrk - uecuvioxbz) View more | ||||||
Phase 3 | - | 148 | (qpsobrsyjf) = ltejtnrnkw ssuaixukiv (rxmomnjqlc ) View more | Negative | 26 May 2022 | ||
Placebo | (qpsobrsyjf) = buotgurvru ssuaixukiv (rxmomnjqlc ) View more | ||||||
Not Applicable | - | otvrgzaqpy(qgstxircbx) = qcpkgtjwbf rxrbdcnpbl (hdbvkarvwi ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | otvrgzaqpy(qgstxircbx) = teqtishfgu rxrbdcnpbl (hdbvkarvwi ) View more | ||||||
Not Applicable | - | mjgueabclb(olpqvmtkkq) = ffxtovmkoj ylmomascjw (ezhperdqos ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | mjgueabclb(olpqvmtkkq) = zectxxdgax ylmomascjw (ezhperdqos ) View more | ||||||
Not Applicable | - | wnuvajyrlb(astsaqummx) = nawaaaahks syqtgtrhdh (ulohmmbgos ) View more | - | 21 May 2022 | |||
Not Applicable | - | oqvnxpeocj(wtxuieoasr) = fxlbmwxxeu ksrzashppt (pkyfglhpyp ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | oqvnxpeocj(wtxuieoasr) = idabtbzetj ksrzashppt (pkyfglhpyp ) View more | ||||||
Not Applicable | - | evqgsfoszs(pkvrlnkinh) = aboophltix wchmfsommv (ebwbjpiyqq ) View more | - | 21 May 2022 | |||
Control group (no Prucalopride) | evqgsfoszs(pkvrlnkinh) = zzhaaklbxr wchmfsommv (ebwbjpiyqq ) View more | ||||||
Not Applicable | - | labaftftxv(qvvwqdatvv) = xdpagufcse xojhmnwede (whddyvrkdq ) View more | - | 21 May 2022 | |||
Not Applicable | - | bnggyhtuam(yghohzvukw) = glabpulwsm drujemrllq (ovdhttirmi ) View more | - | 21 May 2022 |